Pembrolizumab Cutaneous Adverse Events and Their Association With Disease ProgressionMartina Sanlorenzo, Susana Ortiz‐Urda, Adil Daud et al.|JAMA Dermatology|2015Cited by 452
The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Susana Ortiz‐Urda|Molecular Cancer|2024Cited by 14
The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Susana Ortiz‐Urda|Research Square|2023Cited by 1